Profile
Larry Posner worked as a Director at Labopharm, Inc. and as a Principal at Wyeth Holdings LLC from 1983 to 1987.
He was a Senior Vice President at Bayer Corp.
and a Scientific Advisor at Invesco Private Capital, Inc. He also worked as a Senior VP, Head-US Research & Development at Yamanouchi Pharmaceutical Co., Ltd.
in 2003-2004 and as a Senior Vice President-Special Medical Liaison at Bayer Healthcare LLC.
He was an Advisor at POINT Biomedical Corp.
and a Senior Vice President at Bayer Pharmaceuticals Corp.
in 2007.
He was also a General Partner at Vedanta Capital LLC.
Dr. Posner received his undergraduate degree from Brandeis University in 1970, his doctorate from Case Western Reserve University in 1974, and a graduate degree from the University of Connecticut.
Former positions of Larry Posner
| Companies | Position | End |
|---|---|---|
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | 2007-06-30 |
Yamanouchi Pharmaceutical Co., Ltd.
 Yamanouchi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Yamanouchi Pharmaceutical Co. Ltd. manufactures and markets drugs, quasi-drugs and medical devices. It used to promote collaboration with other pharmaceutical companies as well as bioventure companies and academia to raise the quality and speed of its R&D activities. It was founded in 1923. The company was headquartered in Tokyo, JP | Chief Tech/Sci/R&D Officer | 2004-08-31 |
Bayer Healthcare LLC
 Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Corporate Officer/Principal | - |
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Corporate Officer/Principal | 1987-12-30 |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Director/Board Member | - |
Training of Larry Posner
| Case Western Reserve University | Doctorate Degree |
| Brandeis University | Undergraduate Degree |
| University of Connecticut | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Labopharm, Inc.
 Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Health Technology |
Vedanta Capital LLC
 Vedanta Capital LLC Investment ManagersFinance Vedanta Capital LLC (Vedanta Capital) is a venture capital firm founded in 2006 by Parag Phoolchand Saxena, Alessandro A. Piol and Howard E. Goldstein. The firm is headquartered in New York. | Finance |
| Bayer Pharmaceuticals Corp. | |
Yamanouchi Pharmaceutical Co., Ltd.
Yamanouchi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Yamanouchi Pharmaceutical Co. Ltd. manufactures and markets drugs, quasi-drugs and medical devices. It used to promote collaboration with other pharmaceutical companies as well as bioventure companies and academia to raise the quality and speed of its R&D activities. It was founded in 1923. The company was headquartered in Tokyo, JP | Health Technology |
Invesco Private Capital, Inc.
 Invesco Private Capital, Inc. Investment ManagersFinance Invesco Private Capital Inc (Invesco Private Capital) is a private equity and venture capital subsidiary of Invesco North America Group Ltd founded in 1981. The firm is headquartered in New York. | Finance |
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
POINT Biomedical Corp.
 POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Health Technology |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
- Stock Market
- Insiders
- Larry Posner
